These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 6459381)

  • 1. Guinea pig erythrocytes, after their contact with influenza virus, acquire the ability to activate the human alternative complement pathway through virus-induced desialation of the cells.
    Lambré CR; Kazatchkine MD; Maillet F; Thibon M
    J Immunol; 1982 Feb; 128(2):629-34. PubMed ID: 6459381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane.
    Fearon DT
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5867-71. PubMed ID: 293688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Auto-antibody dependent activation of the autologous classical complement pathway by guinea-pig red cells treated with influenza virus or neuraminidase: in vitro and in vivo study.
    Lambre CR; Thibon M; Le Maho S; Di Bella G
    Immunology; 1983 Jun; 49(2):311-9. PubMed ID: 6852870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation by membrane sialic acid of beta1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway.
    Fearon DT
    Proc Natl Acad Sci U S A; 1978 Apr; 75(4):1971-5. PubMed ID: 273923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-surface regulation of the human alternative pathway of complement. Sheep but not rabbit erythrocytes express factor I-dependent cofactor activity.
    Ezzell JL; Parker CJ
    Scand J Immunol; 1992 Jul; 36(1):79-87. PubMed ID: 1535452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of desialated guinea pig erythrocytes with the classical and alternative pathways of guinea pig complement in vivo and in vitro.
    Brown EJ; Joiner KA; Frank MM
    J Clin Invest; 1983 Jun; 71(6):1710-9. PubMed ID: 6863540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autosomal locus regulates inverse relationship between sialic acid content and capacity of mouse erythrocytes to activate human alternative complement pathway.
    Nydegger UE; Fearon DT; Austen KF
    Proc Natl Acad Sci U S A; 1978 Dec; 75(12):6078-82. PubMed ID: 282625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A molecular basis of activation of the alternative pathway of human complement.
    Austen KF; Fearon DT
    Adv Exp Med Biol; 1979; 120B():3-17. PubMed ID: 390986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the alternative complement pathway with rabbit erythrocytes by circumvention of the regulatory action of endogenous control proteins.
    Fearon DT; Austen KF
    J Exp Med; 1977 Jul; 146(1):22-33. PubMed ID: 559720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H.
    Meri S; Pangburn MK
    Proc Natl Acad Sci U S A; 1990 May; 87(10):3982-6. PubMed ID: 1692629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3b.
    Kazatchkine MD; Fearon DT; Silbert JE; Austen KF
    J Exp Med; 1979 Nov; 150(5):1202-15. PubMed ID: 501288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release of soluble immune complexes from immune adherence receptors on human erythrocytes is mediated by C3b inactivator independently of Beta 1H and is accompanied by generation of C3c.
    Medof ME; Prince GM; Mold C
    Proc Natl Acad Sci U S A; 1982 Aug; 79(16):5047-51. PubMed ID: 6214790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.
    Mayes JT; Schreiber RD; Cooper NR
    J Clin Invest; 1984 Jan; 73(1):160-70. PubMed ID: 6418767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ability to activate the alternative complement pathway acquired by human and guinea-pig erythrocytes after contact with influenza virus.
    Lambré C; Thibon M
    Ann Immunol (Paris); 1980; 131C(2):213-21. PubMed ID: 7416718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of C3b bound to pneumococci with factor H (beta 1H globulin), factor I (C3b/C4b inactivator), and properdin factor B of the human complement system.
    Brown EJ; Joiner KA; Gaither TA; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):409-15. PubMed ID: 6223077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of granulocyte histaminase release by particle-bound complement C3 cleavage products (C3b, C3bi) and IgG.
    Melamed J; Medicus RG; Arnaout MA; Colten HR
    J Immunol; 1983 Jul; 131(1):439-44. PubMed ID: 6223078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysine residues, but not carbohydrates, are required for the regulatory function of H on the amplification C3 convertase of complement.
    Jouvin MH; Kazatchkine MD; Cahour A; Bernard N
    J Immunol; 1984 Dec; 133(6):3250-4. PubMed ID: 6238095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of complement activation on the homologous cell membrane of nucleated cells as well as erythrocytes.
    Okada H; Tanaka H; Okada N
    Eur J Immunol; 1983 Apr; 13(4):340-4. PubMed ID: 6221932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins.
    Schreiber RD; Pangburn MK; Lesavre PH; Müller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3948-52. PubMed ID: 279011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residual hemolytic and proteolytic activity expressed by Bb after decay-dissociation of C3b,Bb.
    Fishelson Z; Müller-Eberhard HJ
    J Immunol; 1984 Mar; 132(3):1425-9. PubMed ID: 6229580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.